Cargando…
Pre-clinical development of T-cell immunotherapy for covid-19
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111906/ http://dx.doi.org/10.1016/S1465324921004424 |
| _version_ | 1783690588092104704 |
|---|---|
| author | Smith, C. Panikkar, A. Raju, J. Rehan, S. Lineburg, K. Crooks, P. Ambalathingal Thomas, G. Swaminathan, S. Khanna, R. Matthews, K. Neller, M. |
| author_facet | Smith, C. Panikkar, A. Raju, J. Rehan, S. Lineburg, K. Crooks, P. Ambalathingal Thomas, G. Swaminathan, S. Khanna, R. Matthews, K. Neller, M. |
| author_sort | Smith, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8111906 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | International Society for Cell & Gene Therapy. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81119062021-05-11 Pre-clinical development of T-cell immunotherapy for covid-19 Smith, C. Panikkar, A. Raju, J. Rehan, S. Lineburg, K. Crooks, P. Ambalathingal Thomas, G. Swaminathan, S. Khanna, R. Matthews, K. Neller, M. Cytotherapy Article International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2021-05 2021-05-11 /pmc/articles/PMC8111906/ http://dx.doi.org/10.1016/S1465324921004424 Text en Copyright © 2021 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Smith, C. Panikkar, A. Raju, J. Rehan, S. Lineburg, K. Crooks, P. Ambalathingal Thomas, G. Swaminathan, S. Khanna, R. Matthews, K. Neller, M. Pre-clinical development of T-cell immunotherapy for covid-19 |
| title | Pre-clinical development of T-cell immunotherapy for covid-19 |
| title_full | Pre-clinical development of T-cell immunotherapy for covid-19 |
| title_fullStr | Pre-clinical development of T-cell immunotherapy for covid-19 |
| title_full_unstemmed | Pre-clinical development of T-cell immunotherapy for covid-19 |
| title_short | Pre-clinical development of T-cell immunotherapy for covid-19 |
| title_sort | pre-clinical development of t-cell immunotherapy for covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111906/ http://dx.doi.org/10.1016/S1465324921004424 |
| work_keys_str_mv | AT smithc preclinicaldevelopmentoftcellimmunotherapyforcovid19 AT panikkara preclinicaldevelopmentoftcellimmunotherapyforcovid19 AT rajuj preclinicaldevelopmentoftcellimmunotherapyforcovid19 AT rehans preclinicaldevelopmentoftcellimmunotherapyforcovid19 AT lineburgk preclinicaldevelopmentoftcellimmunotherapyforcovid19 AT crooksp preclinicaldevelopmentoftcellimmunotherapyforcovid19 AT ambalathingalthomasg preclinicaldevelopmentoftcellimmunotherapyforcovid19 AT swaminathans preclinicaldevelopmentoftcellimmunotherapyforcovid19 AT khannar preclinicaldevelopmentoftcellimmunotherapyforcovid19 AT matthewsk preclinicaldevelopmentoftcellimmunotherapyforcovid19 AT nellerm preclinicaldevelopmentoftcellimmunotherapyforcovid19 |